1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Seattle Genetics

Anonymous board for Seattle Genetics


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    81
    Views:
    10,014
  2. anonymous
    Replies:
    7
    Views:
    1,736
  3. anonymous
    Replies:
    5
    Views:
    1,067
  4. Anonymous
    Replies:
    70
    Views:
    53,185
  5. anonymous
    Replies:
    6
    Views:
    5,728
  6. anonymous
    Replies:
    0
    Views:
    3,608
  7. Anonymous
    Replies:
    14
    Views:
    15,489
  8. Anonymous
    Replies:
    5
    Views:
    8,811
  9. Anonymous
    Replies:
    1
    Views:
    4,497
  10. Anonymous
    Replies:
    3
    Views:
    4,631
  11. Anonymous
    Replies:
    6
    Views:
    4,447
  12. Anonymous
    Replies:
    0
    Views:
    2,839
  13. Anonymous
    Replies:
    10
    Views:
    4,840
  14. Anonymous
    Replies:
    10
    Views:
    9,075
  15. Anonymous
    Replies:
    9
    Views:
    7,583
  16. Anonymous
    Replies:
    1
    Views:
    3,735
  17. Anonymous
    Replies:
    14
    Views:
    11,599
  18. Anonymous
    Replies:
    5
    Views:
    5,309
  19. Anonymous
    Replies:
    3
    Views:
    5,731
  20. Paul Revere
    Replies:
    1
    Views:
    6,087

Thread Display Options

Loading...